ACB Registers FIR In Chaudhary Brahm Prakash Ayurved Charak Sansthan Recruitment Fraud Case

New Delhi (PTI): The Anti-Corruption Branch has registered a case against the-then superintendent and other officials of Chaudhary Brahm Prakash Ayurved Charak Sansthan in Delhi’s Najafgarh for alleged irregularities in recruitment, officials said on Monday.

According to a complaint filed by Chaudhary Brahm Prakash Ayurved Charak Sansthan Director-Principal Prof Vidula Gujjarwar, it was alleged that Rajesh Tanwar — the-then office superintendent — had committed irregularities in recruitment and created fake and forged report for postgraduate courses, a senior Anti-Corruption Branch official said.
He committed serious irregularities by not following directions and not linking the recruitment files for postgraduate courses, they said.

A committee was constituted to inquire into the alleged irregularities committed in the recruitment for the posts of associate professor and assistant professor, they said.

According to the inquiry report, Tanwar committed serious irregularities by not following directions and not linking the recruitment files, the official said.

Multiple discrepancies such as manipulation and the creation of additional vacancies without following the norms were observed.

Two candidates — Alok Kumar Asthana and Mukesh Kumar Sharma — did not possess the qualification for the post and were declared not eligible by the first scrutiny committee, Joint Commissioner of Police (Anti-Corruption Branch) Madhur Verma said.

Subsequently, a second scrutiny committee made them eligible and shortlisted them for interview. Later, they were selected and allowed to join the department as associate professors, Verma said.

The inquiry committee submitted its report concluding that the allegations were found substantiated. Following recommendations from the competent authority, a case was registered on Friday under sections of the Indian Penal Code and the Prevention of Corruption Act and it is being investigated, he added.

Related Posts

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

US appeals court sides with Sun Pharma in Lipitor antitrust case

US appeals court sides with Sun Pharma in Lipitor antitrust case

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad